# ZEPOSIA

NDC: 59572-820
Generic name: ozanimod hydrochloride
Labeler / Manufacturer: Celgene Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200327

FDA application: NDA209899

## Active ingredients

- OZANIMOD HYDROCHLORIDE: .92 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59572-820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93ce2fab-edfb-4804-8074-963071de51e4